NCT05279599

Brief Summary

The purpose of this study was to observe the relationship between the changes of circulating extracellular vesicles and disease development and outcome in patients with traumatic brain injury, and to find early serum markers and potential intervention targets for disease monitoring in patients with traumatic brain injury. In addition, explore the source of extracellular vesicles as much as possible to prepare for subsequent basic experiments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2022

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 26, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 15, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

January 26, 2022

Last Update Submit

March 15, 2022

Conditions

Keywords

molecular markersprognosisinflammationperipheral circulation

Outcome Measures

Primary Outcomes (2)

  • The type and content of circulating extracellular vesicles

    After isolation of circulating extracellular vesicles, RNA sequencing was performed to determine noncoding RNA changes in circulating extracellular vesicles. Screening criteria were based on logFC and P value, generally with \|logFC\|\>2 and AP value \<0.05 to define whether there was a difference.

    within 24 hours of TBI

  • Neurological deterioration in patients with traumatic brain injury

    Neurological deterioration (ND) was defined as the occurrence of one or more of the following criteria within 7 days after injury: (a) a decrease in GCS score of 2 points or more from the initial GCS score with no pharmacological sedation; (b) a deterioration in neurological status being sufficient to neurosurgical intervention.

    within 7 days after injury

Secondary Outcomes (2)

  • hospital stay

    From hospitalization to discharge,up to one month

  • GOSE score

    three months or six months

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All TBI patients treated at Tangdu Hospital from January 2022 to December 2022

You may qualify if:

  • No systematic treatment before admission;
  • The patient is diagnosed with traumatic brain injury with imaging evidence;
  • Age \> 18 years old;
  • The patient or family members agree to sign the informed consent.

You may not qualify if:

  • Infectious diseases within the past 1 month;
  • Past head trauma, history of neurological diseases;
  • Non-isolated traumatic brain injury;
  • The patient is not receiving treatment in this hospital;
  • Severe disability, dementia, or organ dysfunction before the onset of the disease;
  • Subject refuses to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tandu Hospital, Fourth Military Medical University

Xi'an, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

1. Peripheral blood was collected in a negative pressure vacuum tube and transferred to the refrigerator -80 for storage as soon as possible. 2. Peripheral blood-related cells are subsequently collected or cultured to observe the relationship between related molecules and circulating extracellular vesicles.

MeSH Terms

Conditions

Brain Injuries, TraumaticInflammation

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Yan Qu, M.D, Ph.D

    Tang-Du Hospital

    STUDY CHAIR
  • Qing Hu, M.D

    Tang-Du Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2022

First Posted

March 15, 2022

Study Start

January 25, 2022

Primary Completion

November 1, 2022

Study Completion

November 1, 2022

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations